FRANKLIN LAKES, N.J. (July 9, 2026) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has been named among the top-performing U.S.-based companies by...

Recognition from Vizient validates CentroVena One™ as a breakthrough innovation designed to simplify central line insertion and enhance patient and clinician safety FRANKLIN LAKES, N.J., June...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has been recognized by the Healthcare Industry Resilience Collaborative (HIRC) as the only supplier to...

2026 recognition underscores the strength of BD’s innovation engine and its contributions to sustainable growth, margin expansion and competitive advantage FRANKLIN LAKES, N.J. (March 6, 2026)...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Urology and Critical Care (UCC) and Surgery business units are the first in...